• SENSEX 77,966.35
    -187.90 (--0.24%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • Tenneco Clean
    524.00 437.85(%)
  • Finolex Cables
    1,375.00 1,375.00(%)
  • Godrej Consumer
    908.00 908.00(%)
  • Max Healthcare
    1,002.00 903.50(%)
  • HDFC Bank
    722.00 722.00(%)
  • TD Power Systems
    1,529.00 1,529.00(%)
  • SBI
    1,085.00 1,234.80(%)
  • Grasim Inds
    3,270.00 2,504.35(%)
  • Hindustan Copper
    569.85 759.20(%)
  • Hindalco Inds.
    1,088.25 1,179.35(%)
  • TCS
    2,301.10 1,976.00(%)
  • Multi Comm. Exc.
    2,987.85 3,479.80(%)
  • Hind.Aeronautics
    5,054.40 5,054.40(%)
  • Fortis Health.
    879.30 767.30(%)
  • Apar Inds.
    18,432.40 18,432.40(%)
  • Axis Bank
    1,216.80 1,041.30(%)
  • Billionbrains
    197.95 227.00(%)
  • Marksans Pharma
    319.90 319.90(%)
  • Ardee Industries
    73.60 73.60(%)
  • LG Electronics
    1,584.00 1,736.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Godavari Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4985.0
  • ISIN : INE362C01012
102.00 -1 (-0.49%)
  • As on 12 Aug 2026 (EOD)

  • Today’s Low

    98.15

  • Today’s High

    103.50

  • Open

    100.05

  • Perv Close

    102.50

  • 52W Low

    69.70

  • 52W High

    135.25

Key Indicators

  • P/E(TTM)

    27.20

  • Mar.Cap (₹Cr.)

    103.30

  • Div & Yield %

    0.00

  • Book Value(₹)

    69.66

  • Debt-Equity Ratio

    -0.49

  • AGM Date

    12-Aug-2026

  • EPS

    3.75

  • P/E Ratio

    27.20

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    103.30

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.13

  • BV (₹)

    69.70

  • Sales( ₹ in Cr.)

    105.81

  • NP (in Cr.)

    3.80

  • NP Var(%)

    -13.0

  • Div%

    0.0

  • CPS (₹)

    6.20

  • EPS (₹)

    3.80

  • Traded Value (₹ in Lakhs)

    103.81

  • 52 Week High

    135.25

  • 52 Week Low

    69.70

  • Price BSE

    103.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    103.81

  • P/C Ratio

    16.70

  • P/E Ratio

    27.40

  • Price Vs.BV

    3.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 113.35 156.71 159.62 161.11 122.67 95.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 113.35 156.71 159.62 161.11 122.67 95.70
Other Income 0.98 0.62 0.88 0.28 0.41 0.33
Stock Adjustments 3.58 1.14 9.76 -2.48 -2.44 0.71
Total Income 117.91 158.47 170.26 158.91 120.64 96.74
EXPENDITURE :            
Raw Materials 85.24 121.95 137.82 127.97 94.15 77.38
Power and Fuel Cost 6.92 8.51 6.66 5.46 4.76 4.84
Employee Cost 5.03 5.13 4.84 4.96 3.94 3.45
Other Manufacturing Expenses 3.19 3.07 3.27 4.14 3.15 1.01
Selling and Administration Expenses 1.46 1.50 1.27 1.38 1.24 1.29
Miscellaneous Expenses 3.27 4.47 5.60 3.42 3.16 2.41
Employee Benefit Expenses 5.03 5.13 4.84 4.96 3.94 3.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 105.10 144.64 159.47 147.33 110.39 90.37
Operating Profit 12.80 13.84 10.81 11.57 10.25 6.36
Interest 4.73 4.92 3.93 2.85 3.32 2.91
Gross Profit 8.07 8.92 6.88 8.72 6.93 3.45
Depreciation 2.45 1.99 1.94 1.70 1.22 1.16
Profit Before Tax 5.62 6.93 4.94 7.02 5.71 2.29
Current Tax 1.19 1.16 1.02 1.23 1.19 0.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.06 0.22 0.13 0.55 0.39 -0.10
Reported Net Profit 4.38 5.55 3.79 5.25 4.13 2.00
Extraordinary Items 0.03 -0.07 0.18 0.00 0.00 0.00
Adjusted Net Profit 4.35 5.62 3.61 5.25 4.13 2.00
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 20.09 14.54 10.75 5.51 1.38 -0.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 24.47 20.09 14.54 10.75 5.51 1.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.82 7.37 5.03 6.97 5.48 2.66
Earnings Per Share(Adj)-Unit Curr 5.82 7.37 5.03 6.97 5.48 2.66
Book Value 57.56 51.74 44.38 39.35 32.38 26.90
Book Value(Adj)-Unit Curr 57.56 51.74 44.38 39.35 32.38 26.90

Shareholding Pattern

  • Promoter Group

    40.23%

  • Public Share Holding

    59.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,074,091 40.23 4,074,091 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,074,091 40.23 4,074,091 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 37,500 0.37 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 127,363 1.26 127,363 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 112,360 1.11 112,360 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 277,223 2.74 239,723 6
2] Non Institution
Bodies Corporate 811,136 8.01 766,136 49
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 394,282 3.89 179,382 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 240,639 2.38 240,639 101
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,437,320 24.07 2,435,220 37
Individuals holding nominal share capital up to Rs. 1 lakh 1,892,744 18.69 1,701,691 6,388
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,776,121 57.03 5,323,068 6,705
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,127,435 100.00 9,636,882 6,722

Company Background

Godavari Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Godavari Drugs Ltd
  • BSE Code : 4985.0
  • ISIN : INE362C01012

  • Incorporation Year

    1987

  • Registered Office

    Mayfair 1-8-303-34
    Sardar Patel Road, Secunderabad,
    Andhra Pradesh-500003

  • Telephone

    91-40-27849700/27844557

  • FAX

    91-40-27849859

  • Chairman

    Ghanshyam Jaju

  • Managing Director

    Mukund Kakani

  • Company Secretary

    Venkatesh Achanta

  • Auditor

    Ayyadevara & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Godavari Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Godavari Drugs 102.00 114.33 113.35 25.25 10.06
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77